Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. GSHD
GSHD logo

GSHD Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Goosehead Insurance Inc (GSHD) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
44.650
1 Day change
1.82%
52 Week Range
114.760
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Goosehead Insurance Inc (GSHD) is not a strong buy for a long-term beginner investor at this time. The technical indicators are mixed, with bearish moving averages and a neutral RSI, while the MACD shows some positive momentum. Options data suggests bearish sentiment with a high put-call volume ratio. Analyst ratings have been consistently lowering price targets, indicating concerns about growth and market conditions. Financial performance shows revenue growth but declining net income and EPS, which could limit long-term upside. Given the lack of strong positive catalysts and the absence of Intellectia Proprietary Trading Signals, it is recommended to hold off on buying this stock for now.

Technical Analysis

The MACD is positive and expanding, indicating some bullish momentum. However, the moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the RSI is neutral at 56.111. The stock is trading near its pivot level of 42.907, with resistance at 45.489 and support at 40.324. Overall, the technical indicators are mixed.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

The high option volume put-call ratio of 1.5 suggests bearish sentiment, while the open interest put-call ratio of 0.22 indicates a relatively higher interest in calls. Implied volatility is high at 78.95, with an IV percentile of 88.8, indicating elevated uncertainty.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
5

Positive Catalysts

  • The company is a growing independent personal lines insurance agency representing over 200 insurance companies. Revenue increased by 12.07% YoY in Q4 2025.

Neutral/Negative Catalysts

  • Analyst ratings have been consistently lowering price targets, citing concerns about market conditions, casualty loss reserves, and potential AI-driven disintermediation. Net income and EPS have declined YoY, and there are no significant hedge fund or insider trading trends. Options data suggests bearish sentiment.

Financial Performance

In Q4 2025, revenue increased by 12.07% YoY to $105.26 million. However, net income dropped by 16.32% YoY to $12.43 million, and EPS declined by 15.79% YoY to 0.48. Gross margin remained flat.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have lowered price targets across the board. Current ratings range from Underperform to Buy, with price targets ranging from $37 to $100. Concerns include market conditions, casualty loss reserves, and potential AI-driven risks.

Wall Street analysts forecast GSHD stock price to rise
11 Analyst Rating
Wall Street analysts forecast GSHD stock price to rise
5 Buy
5 Hold
1 Sell
Moderate Buy
Current: 43.850
sliders
Low
43
Averages
91.7
High
140
Current: 43.850
sliders
Low
43
Averages
91.7
High
140
BofA
Joshua Shanker
Underperform
downgrade
$43 -> $37
AI Analysis
2026-04-14
Reason
BofA
Joshua Shanker
Price Target
$43 -> $37
AI Analysis
2026-04-14
downgrade
Underperform
Reason
BofA analyst Joshua Shanker lowered the firm's price target on Goosehead Insurance to $37 from $43 and keeps an Underperform rating on the shares. The firm adjusted price target among its U.S. insurance coverage to reflect Q4 events and changes to peer multiples.
Citizens
Outperform
maintain
$125 -> $100
2026-04-13
Reason
Citizens
Price Target
$125 -> $100
2026-04-13
maintain
Outperform
Reason
Citizens lowered the firm's price target on Goosehead Insurance to $100 from $125 and keeps an Outperform rating on the shares. The firm expects Q1 results to be highlighted by lighter-than-typical catastrophe losses, modest MTM negative impact on book values and ongoing potential for continued issues around casualty loss reserves. With that said, Citizens believes investor focus will be zeroed in on the pricing environment as weakness in certain areas, notably property, has spooked the market broadly and is now spreading to an increasing number of lines across the industry.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for GSHD
Unlock Now

People Also Watch